chr20-3865825-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The NM_020746.5(MAVS):c.1301G>T(p.Gly434Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020746.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAVS | NM_020746.5 | c.1301G>T | p.Gly434Val | missense_variant | 7/7 | ENST00000428216.4 | |
MAVS | NM_001206491.2 | c.878G>T | p.Gly293Val | missense_variant | 6/6 | ||
MAVS | NM_001385663.1 | c.878G>T | p.Gly293Val | missense_variant | 8/8 | ||
MAVS | NR_037921.2 | n.1265G>T | non_coding_transcript_exon_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAVS | ENST00000428216.4 | c.1301G>T | p.Gly434Val | missense_variant | 7/7 | 1 | NM_020746.5 | P1 | |
MAVS | ENST00000416600.6 | c.878G>T | p.Gly293Val | missense_variant | 6/6 | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250920Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135820
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461686Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727140
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.1301G>T (p.G434V) alteration is located in exon 7 (coding exon 6) of the MAVS gene. This alteration results from a G to T substitution at nucleotide position 1301, causing the glycine (G) at amino acid position 434 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at